Vivesto AB DRC (OASMY)

OTC Markets
Currency in USD
0.020
0.000(0.00%)
Delayed Data·
OASMY Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
Earnings results expected in 3 days
Fair Value
Day's Range
0.0200.020
52 wk Range
0.0100.050
Key Statistics
Edit
Prev. Close
0.02
Open
0.02
Day's Range
0.02-0.02
52 wk Range
0.01-0.05
Volume
-
Average Volume (3m)
100
1-Year Change
-60%
Book Value / Share
0.03
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
OASMY Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Analysts do not anticipate the company will be profitable this year
Show more

Vivesto AB DRC Company Profile

Vivesto AB develops, produces, markets, and sells drugs in the field of human and veterinary oncology in Sweden. Its lead product is Apealea (paclitaxel micellar) for the treatment of ovarian cancer. The company’s products portfolio includes Docetaxel micellar, a patented formulation that combines cytotoxin docetaxel with XR-17, which is in Phase 1b clinical trial for the treatment of prostate cancer; and Cantrixil to treat ovarian cancer. its animal health product portfolio includes Paccal Vet, a formulation of paclitaxel with its XR-17 encapsulation technology for the treatment of canine mastocytoma; and Doxophos Vet, a patented formulation of doxorubicin to treat lymphoma. The company was formerly known as Oasmia Pharmaceutical AB (publ) and changed its name to Vivesto AB in March 2022. Vivesto AB was incorporated in 1988 and is headquartered in Solna, Sweden.

Employees
4

Compare OASMY to Peers and Sector

Metrics to compare
OASMY
Peers
Sector
Relationship
P/E Ratio
−3.2x−6.0x−0.5x
PEG Ratio
−0.05−0.070.00
Price/Book
0.8x3.5x2.6x
Price / LTM Sales
−961.1x55.2x3.0x
Upside (Analyst Target)
-153.4%54.1%
Fair Value Upside
Unlock10.4%8.7%Unlock

Earnings

Latest Release
Feb 20, 2025
EPS / Forecast
-0.04 / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

FAQ

What Is the Vivesto AB DRC (OASMY) Stock Price Today?

The Vivesto AB DRC stock price today is 0.02

What Stock Exchange Does Vivesto AB DRC Trade On?

Vivesto AB DRC is listed and trades on the OTC Markets stock exchange.

What Is the Stock Symbol for Vivesto AB DRC?

The stock symbol for Vivesto AB DRC is "OASMY."

What Is the Vivesto AB DRC Market Cap?

As of today, Vivesto AB DRC market cap is 12.84M.

What Is Vivesto AB DRC's Earnings Per Share (TTM)?

The Vivesto AB DRC EPS (TTM) is -0.07.

When Is the Next Vivesto AB DRC Earnings Date?

Vivesto AB DRC will release its next earnings report on 21 May 2025.

From a Technical Analysis Perspective, Is OASMY a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.